PAS — Pascal Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro Cap

Annual balance sheet for Pascal Biosciences, fiscal year end - November 30th, CAD millions except per share, conversion factor applied.

	2018 November 30th	2019 November 30th	2020 November 30th	2021 November 30th	2022 November 30th
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	3.64	0.361	0	—	0.008
Net Total Accounts Receivable
Net Total Receivables	0.014	0.014	0.084	0.142	0.007
Prepaid Expenses
Total Other Current Assets
Total Current Assets	3.77	0.449	0.094	0.145	0.019
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.05	0.007	0.026	0.01	0
Net Intangible Assets
Total Assets	3.82	0.455	0.121	0.155	0.019
Payable / Accrued
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.227	0.111	0.473	0.646	0.851
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	0.227	0.111	0.473	0.646	0.963
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	3.59	0.344	-0.352	-0.491	-0.944
Total Liabilities & Shareholders' Equity	3.82	0.455	0.121	0.155	0.019
Total Common Shares Outstanding